secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2023-10-17T23:59:59+00:00
Accession:  0001628280-23-034510
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo Therapeutics lowers stockholder meeting quorum from majority to one-third
-------------------------------------------------------------------------------

- Board approved Fourth Amended and Restated Bylaws on October 16, 2023, effective immediately.
- Quorum reduced to one-third of shares entitled to vote, present in person or by proxy.
- Previous requirement was a majority of shares present in person or by proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023034510/0001628280-23-034510-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000162828023034510/avtx-20231016.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-034510

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer